Study guide

2.1 Pathogenesis and Clinical Manifestations of Diabetic Neuropathies

NAWCCB Diabetic Wound Certified DWC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Foot Anatomy and Wound-Healing Physiology

1.1 Structural Anatomy of Plantar and Dorsal Skin, Subcutaneous Tissue, and Plantar Fat Pads 1.2 Osseous, Ligamentous, and Vascular Anatomy of the Foot 1.3 Cellular Phases of Wound Healing and Diabetic Pathophysiologic Impairments 1.4 Nail Unit and Periungual Anatomy Relevant to Diabetic Foot Care 1.5 Functional Neurovascular and Tendon Anatomy of the Foot

2 Chapter 2: Etiology and Pathogenesis of Diabetic Foot Ulcers

2.1 Pathogenesis and Clinical Manifestations of Diabetic Neuropathies 2.2 Peripheral Artery Disease and Microvascular Dysfunction in Diabetes 2.3 The Ulcer Triad: Repetitive Mechanical Stress, Deformity, and Unperceived Trauma

3 Chapter 3: Diagnostic Assessment: Sensory and Biomechanical Testing

3.1 Sensory Assessment and Loss of Protective Sensation (LOPS) 3.2 Biomechanical Assessment, Structural Foot Deformities, and Plantar Pressure Analysis 3.3 Diagnosis and Differential of Acute and Chronic Charcot Neuroarthropathy 3.4 Performance and Interpretation of TBI, Toe PPG, TcPO₂, and Skin Temperature Testing 3.5 Procedural Skills: Nail Trimming and Conservative Sharp Debridement 3.6 Procedural Skills: Total Contact Casting and Residual-Limb Wrapping

4 Chapter 4: Diagnostic Assessment: Vascular, Laboratory, and Imaging Studies

4.1 Bedside Noninvasive Vascular Diagnostics 4.2 Laboratory Evaluation: Inflammatory Markers, Glycemic Control, Nutritional Indices, and Renal Function 4.3 Microbiologic Diagnostics: Deep Tissue Curettage vs. Superficial Swabs, Bone Biopsy, and Culture Interpretation 4.4 Imaging of the Diabetic Foot: Plain Radiographs, Probe-to-Bone Test, MRI, and Nuclear Scintigraphy for Osteomyelitis

5 Chapter 5: Comprehensive Examination and Ulcer Classification

5.1 Patient History, Dermatologic Inspection, and Nail Pathology 5.2 Ulcer Assessment: Measurements, Tissue Characteristics, Exudate, Edges, Undermining, and Tunneling 5.3 Diabetic Foot Ulcer Classification Systems: Wagner Scale and University of Texas System 5.4 PEDIS, IWGDF/IDSA Staging, and SINBAD Classification Systems in Clinical Practice 5.5 Structured Medical, Foot, Medication, Family, and Psychosocial History 5.6 Dermatologic Examination: Diabetic Dermatoses and Nail Disorders 5.7 Structural Foot, Gait, Footwear, Insole, and Sock Examination

6 Chapter 6: Wound Bed Preparation, Debridement, and Advanced Dressings

6.1 Wound Bed Preparation (TIME Principle) and Debridement Modalities 6.2 Exudate Management and Topical Dressings in Diabetic Wound Care 6.3 Advanced Wound Modalities: Negative Pressure Wound Therapy and Cellular/Tissue-Based Products 6.4 Hyperbaric Oxygen Therapy, Biophysical Modalities, and Revascularization Indications 6.5 Treatment of Xerosis, Fissures, Nail Disorders, and Callus 6.6 Individualized Nutrition and Pain Management in Diabetic Foot Care 6.7 The Unsalvageable Foot: Amputation Decisions, Perioperative Care, and Rehabilitation

7 Chapter 7: Offloading Strategies and Biomechanical Interventions

7.1 Offloading Biomechanics and the Gold Standard: Total Contact Casting and Non-Removable Knee-High Devices 7.2 Removable Cast Walkers, Orthotic Walkers, Half-Shoes, and Wedge Offloading 7.3 Surgical Interventions for Pressure Relief: Tendon Lengthening, Metatarsal Head Resection, and Tenotomies

8 Chapter 8: Infection Management and Antimicrobial Stewardship

8.1 Clinical Diagnosis and Severity Grading of Diabetic Foot Infections 8.2 Empiric and Targeted Antimicrobial Therapy, Route Selection, and Antimicrobial Stewardship 8.3 Medical and Surgical Management of Diabetic Foot Osteomyelitis

9 Chapter 9: Prevention Strategies, Patient Education, and Multidisciplinary Care

9.1 IWGDF Risk Stratification Categories and Surveillance Intervals 9.2 Patient and Caregiver Education: Daily Inspection, Hygiene, Temperature Monitoring, and Avoidance of Self-Care Hazards 9.3 Prescription Therapeutic Footwear, Custom Insoles, Depth Shoes, and Rocker Soles 9.4 The Multidisciplinary Diabetic Foot Team: Core Specialties, Communication, and Urgent Referral Triggers 9.5 Annual Screening and Treatment of Pre-Ulcerative Signs 9.6 Metabolic Risk Reduction, Nutrition, Glucose Management, and Safe Activity 9.7 Inclusive Education, Ethical Care, Legal Duties, and Apparent Nonadherence

2.1 Pathogenesis and Clinical Manifestations of Diabetic Neuropathies

Key Takeaways Explain This Topic AI

Diabetic peripheral neuropathy (DPN) develops via complex metabolic and ischemic cascades: aldose reductase flux with NADPH depletion, advanced glycation end-products (AGEs), protein kinase C (PKC) activation, and endoneurial microvascular ischemia.

Sensory neuropathy exhibits a length-dependent 'glove-and-stocking' symmetrical distribution, initially damaging small fibers (pain, temperature, burning paresthesias) before destroying large fibers (vibration, light touch, proprioception), resulting in loss of protective sensation (LOPS).

Motor neuropathy denervates intrinsic lumbrical and interosseous foot muscles, allowing extrinsic long flexors and extensors to overpower the digits, producing claw toe deformities and distal displacement of the shock-absorbing submetatarsal fat pad.

Autonomic neuropathy eliminates sudomotor sweating (anhidrosis, xerosis, deep fissuring) and causes dermal arteriovenous (AV) shunting, producing a deceptively warm foot with bounding pulses despite deep nutritive capillary starvation.

Loss of sympathetic vascular tone and unchecked hypervascular bone perfusion promote osteoclast activation and bone demineralization, predisposing the tarsal and midfoot joints to Charcot neuroarthropathy.

Last updated: September 2026

Pathogenesis and Clinical Manifestations of Diabetic Neuropathies

Diabetic peripheral neuropathy ( DPN ) is the single most common and consequential precursor to diabetic foot ulceration ( DFU ), implicated in more than 80% of all lower-extremity ulcerations in patients with diabetes mellitus. Far from being a simple loss of feeling, diabetic neuropathy represents a multifaceted, progressive neurodegenerative disorder affecting sensory, motor, and autonomic nerve fibers. Understanding the intricate molecular pathways that damage peripheral axons and recognizing their direct clinical consequences is foundational to certified diabetic wound care practice.

1. Multifactorial Molecular Pathogenesis

The cellular destruction of peripheral nerves in diabetes stems from a synergistic combination of intracellular metabolic derangements and endoneurial microvascular ischemia . Sustained extracellular hyperglycemia overwhelms intracellular glucose processing within neurons and Schwann cells, triggering four distinct, interconnected pathological pathways: Chronic Hyperglycemia

  • │
  • ┌──────────────────┬───────────────┴───────────────┬──────────────────┐
  • ▼ ▼ ▼ ▼
  • Polyol Pathway AGE Accumulation PKC Activation Mitochondrial ROS
  • (Aldose Reductase) (RAGE Activation) (PKC-β & PKC-δ) (Superoxide / PARP)
  • │ │ │ │
  • NADPH Depletion NF-κB Induction Endothelin-1 ↑ DNA Strand Breaks
  • GSH Depletion TNF-α / IL-1β ↑ eNOS Decrease NAD+ / ATP Collapse
  • │ │ │ │
  • └──────────────────┴───────────────┬───────────────┴──────────────────┘
  • ▼
  • Endoneurial Microvascular Ischemia
  • ▼
  • Axonal Dying-Back Degeneration
  • The Polyol (Sorbitol) Pathway

Under physiological euglycemia, hexokinase phosphorylates approximately 97% of intracellular glucose into glucose-6-phosphate. In chronic hyperglycemia, hexokinase becomes saturated, shunting up to 30% of intracellular glucose into the polyol pathway :

Aldose reductase reduces glucose into sorbitol , consuming nicotinamide adenine dinucleotide phosphate (NADPH) as an obligate hydrogen donor.

Sorbitol dehydrogenase subsequently oxidizes sorbitol into fructose , converting NAD+ to NADH.

This pathway exerts two devastating cellular effects:

Osmotic Stress and Myo-Inositol Depletion: Sorbitol is a polar, membrane-impermeant hexitol that accumulates within axons and Schwann cells, generating intracellular hyperosmotic swelling. Intracellular sorbitol accumulation competitively inhibits the active sodium-dependent uptake of myo-inositol . Because myo-inositol is an indispensable precursor of phosphoinositide signaling, its depletion inactivates the membrane-bound Na+/K+-ATPase pump , retarding nerve action potential conduction velocity.

NADPH Exhaustion and Oxidative Stress: The overconsumption of cytosolic NADPH by aldose reductase deprives glutathione reductase of its critical electron donor. Consequently, oxidized glutathione ( GSSG ) cannot be regenerated into reduced glutathione ( GSH ), the cell's principal endogenous free-radical scavenger. Stripped of antioxidant protection, peripheral nerves sustain catastrophic lipid peroxidation and mitochondrial structural decay.

Advanced Glycation End-Products (AGEs) and RAGE Signaling

Persistent hyperglycemia drives the non-enzymatic condensation of reducing sugars with free amino groups on structural and circulating proteins—the Maillard reaction . These unstable Schiff bases undergo Amadori rearrangements to form irreversible, covalent cross-links termed advanced glycation end-products (AGEs) .

Extracellular Matrix Glycation: AGEs cross-link endoneurial collagen and laminin, stiffening the perineurium and thickening microvascular basement membranes.

RAGE Activation: Binding of AGEs to the Receptor for Advanced Glycation Endproducts (RAGE) on Schwann cells and endoneurial endothelial cells triggers sustained activation of the transcription factor nuclear factor kappa B (NF-κB) . This induces transcription of pro-inflammatory cytokines—including tumor necrosis factor-alpha (TNF-α) , interleukin-1 beta (IL-1β) , and interleukin-6 (IL-6) —and upregulates vascular adhesion molecules, inciting chronic neurovascular inflammation and quenching bioavailable nitric oxide (NO) .

Protein Kinase C (PKC) Activation

Elevated levels of intracellular dihydroxyacetone phosphate and glyceraldehyde-3-phosphate stimulate the de novo synthesis of diacylglycerol (DAG) . Elevated DAG persistently activates calcium-dependent protein kinase C (PKC) isoforms, predominantly PKC-β and PKC-δ . Pathologic PKC signaling causes:

Upregulation of endothelin-1 , a potent endogenous vasoconstrictor.

Suppression of endothelial nitric oxide synthase (eNOS) , halting basal vasodilation.

Hyper-expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta (TGF-β), driving hyperpermeability, capillary basement membrane thickening, and pericyte detachment.

Mitochondrial Superoxide and PARP Hyperactivation

Overloaded electron transport chains in hypermetabolic neuronal mitochondria generate immense surpluses of superoxide anion (O2•-) . Superoxide inhibits glyceraldehyde-3-phosphate dehydrogenase (GAPDH), forcing all upstream glycolytic intermediates into the toxic pathways described above. When superoxide reacts with local nitric oxide, it generates peroxynitrite (ONOO-) , a ferocious reactive nitrogen species that induces extensive single-strand DNA breaks. Cellular DNA damage hyper-activates the nuclear repair enzyme poly(ADP-ribose) polymerase (PARP) , which rapidly consumes intracellular stores of NAD+ and ATP, precipitating cellular energy exhaustion and distal axonal suicide.

Endoneurial Microvascular Ischemia

The peripheral nerve trunk relies on a delicate microvascular supply: the vasa nervorum . The convergence of pericyte apoptosis, basement membrane hyalinization, endothelial cell swelling, and endothelin-mediated vasoconstriction causes severe endoneurial microvascular hypoperfusion. The resulting endoneurial hypoxia starves long axonal cylinders of essential oxygen and glucose, initiating a length-dependent, distal-to-proximal axonal degeneration known as "dying-back" neuropathy .

2. The Clinical Triad of Diabetic Neuropathy

Diabetic peripheral neuropathy manifests across three interrelated neurological domains: sensory , motor , and autonomic . Each domain produces distinct clinical deficits that coalesce to render the foot extraordinarily vulnerable to ulceration. THE NEUROPATHIC CLINICAL TRIAD

  • │
  • ┌───────────────────────────────┼───────────────────────────────┐
  • ▼ ▼ ▼
  • SENSORY NEUROPATHY MOTOR NEUROPATHY AUTONOMIC NEUROPATHY
  • Length-dependent dying-back • Intrinsic foot muscle • Sudomotor denervation
  • "glove-and-stocking" loss atrophy (lumbricals/ (anhidrosis, xerosis,
  • Small-fiber: thermal/pain interossei) deep fissures)
  • loss, burning paresthesias • Extrinsic flexor/extensor • Vasomotor AV shunting
  • Large-fiber: vibration, overpower (warm foot, bounding
  • light touch, proprioception • Claw / hammer toe deformities pulses, steal ischemia)
  • Loss of Protective Sensation • Distal fat pad migration • Hyperemic osteoclast
  • (LOPS: 10-g monofilament) • Plantar peak pressure spikes resorption (Charcot)
  • Sensory Neuropathy: The Loss of the Biological Alarm

Sensory neuropathy in diabetes is characteristically a distal symmetric polyneuropathy (DSPN) with an insidious, length-dependent onset. Long peripheral nerve fibers supplying the toes and distal feet degenerate first, producing the hallmark symmetrical "glove-and-stocking" pattern of sensory deficit.

Small-Fiber vs. Large-Fiber Involvement

Sensory modalities deteriorate according to fiber diameter and myelination:

Small-Fiber Neuropathy (Unmyelinated C-fibers and thinly myelinated Aδ-fibers): Small fibers mediate thermal discrimination (cold and warm) and superficial nociception (pinprick). Early small-fiber damage frequently presents with "positive" neuropathic symptoms, including burning sensations, lancinating electric-shock pains, dysesthesias, hyperalgesia, and contact allodynia (pain elicited by bedsheets touching the feet). Symptoms characteristically worsen at night. As degeneration advances, positive symptoms burn out, leaving silent thermal and sharp pain anesthesia.

Large-Fiber Neuropathy (Heavily myelinated Aβ-fibers): Large fibers transmit light touch perception, vibration sensation, and proprioceptive joint position. Large-fiber loss manifests as "negative" sensory deficits: numbness, the sensation of "walking on wadded socks or cotton," sensory ataxia, unsteady gait, and absent deep tendon reflexes (specifically the Achilles reflex).

Loss of Protective Sensation (LOPS)

The critical clinical milestone is the development of Loss of Protective Sensation (LOPS) . Under physiological conditions, mechanical pressures exceeding 200–300 kPa trigger pain, compelling an individual to shift weight, alter gait, or remove constrictive footwear. Loss of protective sensation is identified with a standardized 10-g monofilament protocol plus another neurologic modality. Repeated site responses and the overall pattern—not one uncertain touch—show that protective feedback is impaired. The patient continues to walk upon blistered, foreign-body-penetrated, or shear-stressed plantar tissues without awareness, driving tissue necrosis to full-thickness ulceration.

Motor Neuropathy: Structural Deformity and Focal Pressure Spikes

Motor neuropathy in the diabetic foot predominantly targets the distal motor branches of the medial and lateral plantar nerves (branches of the tibial nerve), resulting in progressive denervation, fatty infiltration, and atrophy of the intrinsic foot musculature —specifically the interossei, lumbricals, flexor digitorum brevis, and abductor hallucis.

Muscular Imbalance and Digital Contractures

Under normal anatomy, the intrinsic muscles stabilize the metatarsophalangeal ( MTP ) joints and extend the interphalangeal joints during terminal stance and toe-off. When intrinsic muscles atrophy, the stronger extrinsic long muscles originating in the calf—namely the extensor hallucis longus (EHL) , extensor digitorum longus (EDL) , flexor hallucis longus (FHL) , and flexor digitorum longus (FDL) —exert unopposed mechanical pull on the digits:

Claw Toe Deformity: Hyperextension at the MTP joint coupled with flexion at both the proximal interphalangeal ( PIP ) and distal interphalangeal ( DIP ) joints.

Hammer Toe Deformity: Hyperextension at the MTP joint, hyperflexion at the PIP joint, and neutral-to-extended position of the DIP joint.

Mallet Toe Deformity: Isolated hyperflexion at the DIP joint.

Submetatarsal Fat Pad Displacement

During progressive MTP joint hyperextension (dorsal subluxation of the proximal phalanx), a retrograde mechanical vector forces the metatarsal head plantarward. Simultaneously, the proximal phalanx drags the deep plantar fascia and the submetatarsal plantar fat pad distally into the subdigital sulcus. Deprived of its natural fibroelastic, shock-absorbing cushion, the metatarsal head is covered only by thin, non-cushioned subcutaneous tissue. During dynamic ambulation, localized peak plantar pressures under the metatarsal heads (most commonly the 1st, 2nd, and 5th) and the apices/dorsal crests of contracted digits escalate to dangerous levels (400–800+ kPa), initiating subcutaneous shear and tissue death.

Autonomic Neuropathy: Cutaneous Barrier Collapse and Microvascular Steal

Diabetic autonomic neuropathy ( DAN ) disrupts both the sudomotor (sweat gland innervation) and vasomotor (vascular tone) sympathetic nervous systems of the lower extremity.

Sudomotor Denervation: Xerosis and Fissures

Postganglionic sympathetic unmyelinated C-fibers innervating the dermal eccrine sweat glands undergo early neurodegeneration, causing anhidrosis (complete cessation of perspiration). Deprived of natural aqueous moisture and epidermal barrier lipids, the stratum corneum suffers severe xerosis , loss of tensile elasticity, and thick hyperkeratotic plaque formation. Under dynamic walking forces, unyielding dry skin splits into deep calcaneal and plantar fissures . These painful or insensate dermal cracks breach the primary physical barrier, establishing direct conduits for Staphylococcus aureus , Streptococcus pyogenes , and polymicrobial pathogens into the deep subcutaneous space.

Vasomotor Denervation: Arteriovenous (AV) Shunting and the "Warm Foot" Paradox

Sympathetic adrenergic tone normally maintains baseline tonic constriction in cutaneous arterioles and precapillary sphincters. Sympathetic denervation paralyzes this vascular tone, forcing the opening of low-resistance dermal arteriovenous (AV) anastomoses (glomus bodies). Blood bypasses high-resistance nutritive capillary beds, shunting directly from dermal arterioles into superficial subpapillary venous plexuses.

Clinical Exam Trap: The "Warm, Well-Perfused" Insensate Foot

Clinicians unfamiliar with diabetic neurovascular physiology frequently examine a warm, pink, erythematous foot with bounding dorsalis pedis pulses and distended dorsal foot veins, incorrectly charting that arterial circulation is excellent. In reality, this presentation reflects profound autonomic sympathectomy with arteriovenous shunting . While superficial blood volume is elevated, the deep dermal and subepidermal tissues suffer from functional capillary starvation (nutritive steal phenomenon) . The skin is warm yet ischemic at the microscopic cellular level.

Hyperemic Osteopenia and Charcot Neuroarthropathy Predisposition

The loss of sympathetic vasoconstriction does not stop at the skin; it increases resting osseous blood flow. Sustained hypervascular perfusion of cancellous bone activates osteoclasts , driving localized osteopenia and demineralization. Combined with sensory loss and repetitive mechanical trauma, this bone demineralization sets the stage for trabecular microfractures, periarticular ligamentous laxity, and devastating midfoot joint subluxation known as acute Charcot neuroarthropathy .

3. Summary of Neuropathic Manifestations and DFU Risks

Neuropathy Component Primary Anatomic Target Pathophysiological Mechanism Clinical Signs & Physical Findings Direct DFU Complication Risk

Sensory Neuropathy Small unmyelinated C-fibers, thinly myelinated Aδ-fibers, large myelinated Aβ-fibers Polyol pathway flux, NADPH depletion, AGE cross-linking, mitochondrial ROS, endoneurial ischemia Burning paresthesias, stocking-glove numbness, loss of thermal/vibration sense, LOPS on standardized monofilament plus companion testing Unperceived mechanical trauma, foreign body penetration, blisters, unnoticed callus autolysis

Motor Neuropathy Lumbricals, interossei, flexor digitorum brevis (tibial nerve branches) Axonal dying-back denervation and fatty atrophy of intrinsic pedal muscles Claw toes, hammer toes, hallux malleus, distal fat pad migration, prominent metatarsal heads Focal peak plantar pressure spikes (400–800 kPa), dorsal toe ulcerations from shoe upper friction, submetatarsal ulcers

Autonomic Neuropathy (Sudomotor) Dermal eccrine sweat glands Sympathetic postganglionic unmyelinated C-fiber denervation Anhidrosis, severe cutaneous xerosis, scaling, thick hyperkeratosis, loss of skin elasticity Deep plantar and heel fissures serving as bacterial entry portals for cellulitis and deep space abscesses

Autonomic Neuropathy (Vasomotor & Osseous) Dermal precapillary sphincters, AV anastomoses, periosteal microvessels Loss of sympathetic vasoconstrictor tone; continuous dilation of glomus shunts; hyperemic bone perfusion Warm foot, bounding pedal pulses, distended dorsal veins, functional capillary steal, osteopenia Microcirculatory tissue hypoxia, impaired wound edge healing, ligamentous laxity, acute Charcot collapse